Mylan First Quarter Profit up 8%, Eyeing Acquisitions

Thu, 05/01/2014 - 11:34am

CANONSBURG, Pa. (AP) — Mylan's first-quarter net income rose about 8 percent, and the generic drugmaker said Thursday that it is still hunting for acquisitions and it expects to pull off a "substantial transaction" this year.

The Canonsburg, Pennsylvania-based company has been pursuing Swedish pharmaceutical company Meda. But Meda said Monday that it had rejected Mylan's latest buyout offer.

Mylan CEO Heather Bresch said Thursday in a statement announcing the company's first quarter that Mylan is still exploring a number of possible deals. She did not offer details.

In the January-March period, Mylan earned $115.9 million, or 29 cents per share. That compares with $106.9 million, or 27 cents per share, in last year's quarter.

Adjusted results totaled 66 cents per share, which topped analyst expectations by 2 cents.

Revenue rose 5 percent to about $1.72 billion. Analysts forecast $1.79 billion, according to FactSet.

Bresch said the quarter's performance "slightly exceeded" the company's expectations.

Mylan shares were inactive in premarket trading. They have gained 17 percent this year.


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.